Result of AGM
SkinBioTherapeutics plc announced that all resolutions were passed at its Annual General Meeting, with strong support for the re-appointment of auditors and director remuneration. Key resolutions regarding the allotment of securities for cash, both generally and for acquisitions, also received significant backing, with votes for ranging from 80.84% to 81.34%, indicating shareholder confidence in the company's strategic financial flexibility.
Select text to share a quote on X · sign in to keep highlights & notes in your SBTX notes
29 December 2025 - SkinBioTherapeutics plc, (AIM: SBTX, or the "Company"), a life science company focused on skin health, held its Annual General Meeting today and all resolutions were passed.
| Resolution | Votes For | Votes Against | Votes Withheld | ||
|---|---|---|---|---|---|
| 1. To receive the annual report and accounts | 88,024,558 | 83.50% | 17,391,981 | 16.50% | 722,198 |
| 2. To re-appoint Gravita as auditor | 96,998,314 | 92.15% | 8,266,920 | 7.85% | 873,503 |
| 3. To authorise Directors to determine Auditors renumeration | 97,093,358 | 92.13% | 8,296,876 | 7.87% | 748,503 |
| 4. To authorise the Directors to allot relevant securities | 85,828,638 | 80.90% | 20,268,099 | 19.10% | 42,000 |
| 5. To authorise the Directors to allot equity securities for cash without a pre-emptive offer to shareholders | 85,771,888 | 80.84% | 20,324,849 | 19.16% | 42,000 |
| 6. To authorise the Directors to allot equity securities for cash in relation to an acquisition of other capital investment | 85,782,499 | 81.34% | 19,682,546 | 18.66% | 673,692 |
An electronic copy of the Annual Report and Accounts is available and the results of the AGM will be available on the Company's website in due course at www.skinbiotherapeutics.com/investor-relations.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.